Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,225 | 5,506 | 6,989 | 9,144 | 10,944 |
| TOTAL | $7,225 | $5,506 | $6,989 | $9,144 | $10,944 |
| Non-Current Assets | |||||
| Intangibles | 4 | 5 | 5 | 6 | 7 |
| TOTAL | $4 | $5 | $5 | $6 | $7 |
| Total Assets | $7,229 | $5,511 | $6,995 | $9,150 | $10,951 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,335 | 347 | 256 | 231 | 301 |
| Other current liabilities | 18 | 43 | 38 | 66 | 1 |
| TOTAL | $1,353 | $390 | $294 | $297 | $302 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,353 | $390 | $294 | $297 | $302 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,145 | 12,880 | 12,878 | 12,848 | 12,848 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -55,445 | -52,838 | -50,365 | -47,618 | -45,226 |
| TOTAL | $5,875 | $5,121 | $6,700 | $8,853 | $10,650 |
| Total Liabilities And Equity | $7,228 | $5,511 | $6,995 | $9,150 | $10,951 |